▲ Peaking
Health
Tirzepatide in Adolescents With Obesity The SURMOUNT-ADOLESCENTS Randomized Clinical Trial
Tirzepatide led to substantial BMI reductions in adolescents with obesity during the phase III SURMOUNT-ADOLESCENTS trial.
4 trends tracked about this subject — the full history, oldest to newest below.
Tirzepatide led to substantial BMI reductions in adolescents with obesity during the phase III SURMOUNT-ADOLESCENTS trial.
Recent studies reveal distinct brain activity patterns and structural links in depression treatment, advancing precision psychiatry.
New research suggests a link between smartphone ownership at age 12 and an increased risk of disordered eating in children.
Recent studies link early smartphone ownership among young children to a higher risk of developing eating disorders.